[Federal Register Volume 61, Number 168 (Wednesday, August 28, 1996)]
[Notices]
[Pages 44313-44314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-21924]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee (NVAC), Subcommittee on 
Vaccine Safety, Subcommittee on Immunization Coverage, Subcommittee on 
Future Vaccines, and the Advisory Commission on Childhood Vaccines 
(ACCV), Subcommittee on Vaccine Safety: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-1:30 p.m., September 9, 1996. 8:30 a.m.-
12:30 p.m., September 10, 1996.
    Place: Hubert H. Humphrey Building, Room 702A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
so they can be escorted to the meeting. Entrance to the meeting at 
other times during the day cannot be assured.
    Purpose: The Committee shall advise and make recommendations to 
the Director of the National Vaccine Program on matters related to 
the Program responsibilities.
    Matters to be Discussed: The Committee will receive reports on 
the status of NVAC nominees to replace members whose terms have 
ended, status of new exofficio members from the Department of 
Agriculture and the Health Care Financing Administration, and a 
discussion regarding the addition of liaison representatives to the 
Committee; the recruitment status for the Director, National Vaccine 
Program Office (NVPO); update alternatives for adverse event 
surveillance and funding options; update immunization registry: 
confidentiality issues; NVAC endorsement of the immunization 
information system confidentiality paper; update philosophical 
exemption to immunization; the Measles Vaccine Timing Study--
Discussion of Edmonston-Zagreb (EZ) Vaccine Study; Institutes of 
Medicine risk communication safety forum; an update on the 
Subcommittee on Immunization Coverage Draft Papers, Thirteen Points 
of Leverage to Increase Coverage and Access to Immunization; an 
update on the Subcommittee on Future Vaccines, vaccine research 
partnership, and a status report on Sabin case studies; an update on 
the Subcommittee on Vaccine Safety; update on Adult Immunization 
Work Group; report on children's vaccine initiative; update on the 
National Vaccine Injury Compensation Program, a report from the Task 
Force on Safer Vaccines, a review of adverse events litigation and 
compensation in adults; and an update on Acellular Pertussis.
    Agenda items are subject to change as priorities dictate.
    Name: NVAC Subcommittee on Vaccine Safety and the ACCV, 
Subcommittee on Vaccine Safety.
    Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint ACCV/NVAC subcommittee will review issues 
relevant to

[[Page 44314]]

vaccine safety and adverse reactions to vaccines.
    Matters to be Discussed: The Subcommittee will discuss the 
inclusion of influenza and pneumococcal vaccines in the National 
Vaccine Injury Compensation Program summation, direction and 
closure; focus of safety subcommittees; and a review of report and 
recommendations from the Task Force on Safer Childhood Vaccines.
    Name: NVAC Subcommittee on Immunization Coverage.
    Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
    Place: Hubert H. Humphrey Building, Room 423A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be Discussed: The Subcommittee will discuss the forum 
on assessment and related immunization issues; the outline for the 
Subcommittee's report; and the assessment of immunization coverage.
    Name: NVAC Subcommittee on Future Vaccines.
    Time and Date: 1:30 p.m.-5 p.m., September 9, 1996.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will develop policy options and guide 
the National Vaccine Program activities which will lead to 
development, licensure, and best use of new and existing vaccines in 
the simplest possible immunization schedules.
    Matters to be Discussed: The Subcommittee will discuss updates 
on vaccine procurement strategies, the United States Agency for 
International Development vaccine research agenda, and a discussion 
of case studies in vaccine development.
    Contact Person for More Information: Felecia D. Pearson, 
Committee Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, 
M/S D50, Atlanta, Georgia 30333, telephone 404/639-7250.

    This notice is being published less than 15 days prior to the 
meeting due to the inability to transmit the document electronically.

    Dated: August 22, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 96-21924 Filed 8-27-96; 8:45 am]
BILLING CODE 4163-18-M